The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer

Niranjan Awasthi, Peter L. Yen, Margaret A. Schwarz, Roderich E. Schwarz

Research output: Contribution to journalArticlepeer-review

62 Scopus citations

Fingerprint

Dive into the research topics of 'The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds